Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0118 EUR | -5.60% | -15.11% | -80.72% |
05/07 | BioSenic Seeks US Patent Extension for Sepsis Drug | MT |
02/07 | BioSenic, Phebra Update Licensing Terms for Oral Arsenic Trioxide Drug Development | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-80.72% | 3.42M | |
+56.20% | 848B | |
+31.64% | 627B | |
-0.18% | 363B | |
+15.32% | 318B | |
+12.99% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.21% | 179B | |
+3.96% | 167B |
- Stock Market
- Equities
- BIOS Stock
- News BioSenic SA
- BioSenic Seeks US Patent Extension for Sepsis Drug